Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:24 AM
Ignite Modification Date:
2025-12-25 @ 4:24 AM
NCT ID:
NCT05818020
Eligibility Criteria:
Inclusion Criteria:
* Diagnosis of any of the following diseases:
1. breast cancer;
2. melanoma;
3. hepatocarcinoma;
4. gynecological cancer;
5. colorectal cancer;
6. lung cancer.
7. sarcoma;
8. pancreatic tumor;
9. tumor of endocrine glands (thyroid);
10. digestive system tumor (classifying rare ones);
11. urological and/or male genital tumor (classifying rare ones);
12. female genital tumor (classifying rare ones);
13. rare skin tumor;
* Signature of the informed consent for the study.
* Age 18 years
* Biological material leftover from biopsy or surgery, and the residual to the activities of clinical assistance analysis.
* No ongoing treatment for oncological diseases at the time of collection.
Exclusion Criteria:
Patients meeting any of the following criteria are not eligible for the present study:
* Patients aged \< 18 years;
* Patients who have not signed the informed consent;
* Positive history of previous neoplasms (only for "naive" patients);
* Positive history of synchronous/metachronous oncological pathologies different from those specified for recruitment (only for "naive" patients);
* Ongoing immunosuppressive therapy (only for "naive" patients).
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05818020
Study Brief:
Protocol Section:
NCT05818020